Standardized template for clinical reporting of PSMA PET/CT scans Journal Article


Authors: Esfahani, S. A.; Morris, M. J.; Sartor, O.; Frydenberg, M.; Fanti, S.; Calais, J.; Vapiwala, N.
Article Title: Standardized template for clinical reporting of PSMA PET/CT scans
Abstract: Purpose: Accurate diagnosis and staging of prostate cancer are crucial to improving patient care. Prostate-specific membrane antigen (PSMA)-targeted positron emission tomography with computed tomography (PET/CT) imaging has demonstrated superiority for initial staging and restaging in patients with prostate cancer. Referring physicians and PET/CT readers must agree on a consistent communication method and application of information derived from this imaging modality. While several guidelines have been published, a single PSMA PET/CT reporting template has yet to be widely adopted. Based on the consensus from community and academic physicians, we developed a standardized PSMA PET/CT reporting template for radiologists and nuclear medicine physicians to report and relay key imaging findings to referring physicians. The aim was to improve the quality, clarity, and utility of imaging results reporting to facilitate patient management decisions. Methods: Based on community and expert consensus, we developed a standardized PSMA PET/CT reporting template to deliver key imaging findings to referring clinicians. Results: Core category components proposed include a summary of any prior treatment history; presence, location, and degree of PSMA radiopharmaceutical uptake in primary and/or metastatic tumor(s), lesions with no uptake, and incidentally found lesions with positive uptake on PET/CT. Conclusions: This article provides recommendations on best practices for standardized reporting of PSMA PET/CT imaging. The generated reporting template is a proposed supplement designed to educate and improve data communication between imaging experts and referring physicians. © The Author(s) 2024.
Keywords: medical oncologist; bone metastasis; cancer staging; nuclear magnetic resonance imaging; positron emission tomography; pelvis lymph node; diagnostic accuracy; prostate specific antigen; metabolism; consensus; spleen; diagnostic imaging; risk assessment; mathematical model; prostate cancer; gleason score; prostatic neoplasms; standard; patient care; liver metastasis; lung metastasis; membrane antigen; liver; prostate specific membrane antigen; prostate; kidney; radiologist; image enhancement; reference standards; computerized tomography; image quality; prostate tumor; diagnosis; urology; brain metastasis; physician; visceral metastasis; clinical decision making; nuclear medicine; salivary gland; inguinal lymph node; ureter; seminal vesicle; university hospital; false positive result; sacrum; prostate cancers; diseases; glutamate carboxypeptidase ii; antigens, surface; pet/ct; rectum; bladder; standardized uptake value; medical history; guideline; internal iliac artery; community hospital; procedures; report; urologist; digestive system; psma; metastatic prostate cancer; prostate-specific membrane antigens; humans; human; male; article; computed tomography scan; radiation oncologist; best practice; multidisciplinary team; positron emission tomography-computed tomography; positron emission tomography computed tomography; supraclavicular lymph node; folh1 protein, human; reporting and data system; clinical reporting; tomography imaging; obturator artery; lacrimal duct; common iliac artery; external iliac artery; communication method; positron emission tomography with computed tomography; abdominal lymph node; penile metastasis; perirectal artery; standardized reporting of psma pet ct imaging; thoracic lymph node
Journal Title: European Journal of Nuclear Medicine and Molecular Imaging
Volume: 52
Issue: 1
ISSN: 1619-7070
Publisher: Springer  
Date Published: 2024-12-01
Start Page: 335
End Page: 341
Language: English
DOI: 10.1007/s00259-024-06857-w
PUBMED: 39143250
PROVIDER: scopus
PMCID: PMC11599343
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Morris
    582 Morris